Highlights and Quick Summary
- EBITDA Margin for the quarter ending June 30, 2023 was 0.0% (a NaN% decrease compared to previous quarter)
- Year-over-year quarterly EBITDA Margin decreased by NaN%
- Annual EBITDA Margin for 2022 was 0.0% (a NaN% decrease from previous year)
- Annual EBITDA Margin for 2021 was 0.0% (a NaN% decrease from previous year)
- Annual EBITDA Margin for 2020 was 0.0% (a NaN% decrease from previous year)
- Twelve month EBITDA Margin ending June 30, 2023 was 0.0% (a NaN% decrease compared to previous quarter)
- Twelve month trailing EBITDA Margin decreased by NaN% year-over-year
Trailing EBITDA Margin for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| 0.0% | 0.0% | 0.0% | 0.0% |
Visit stockrow.com/DYN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EBITDA Margin of Dyne Therapeutics, Inc.
Most recent EBITDA Marginof DYN including historical data for past 10 years.Interactive Chart of EBITDA Margin of Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. EBITDA Margin for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 0.0% | 0.0% | – | – | – |
| 2022 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| 2021 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| 2020 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| 2019 | – | – | – | 0.0% | 0.0% |
| 2018 | – | – | – | – | 0.0% |
Business Profile of Dyne Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology